Share Price and Basic Stock Data
Last Updated: November 22, 2025, 8:31 am
| PEG Ratio | 2.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Foseco India Ltd operates in the Chemicals sector, specifically focusing on organic chemicals. The company reported a current market price of ₹5,322 and a market capitalization of ₹3,396 Cr. Over the years, Foseco has shown a consistent upward trajectory in sales, with reported revenues standing at ₹407 Cr in December 2022, rising to ₹477 Cr in December 2023, and further increasing to ₹525 Cr in December 2024. The trailing twelve months (TTM) revenue reached ₹593 Cr, indicating a robust growth trend. Quarterly sales figures also reflect this positive trajectory, with June 2022 sales starting at ₹100 and increasing to ₹123 by September 2023, ultimately reaching ₹149 by March 2025. This growth can be attributed to effective market strategies and a strong demand for the company’s products, positioning Foseco favorably against typical sector performance benchmarks.
Profitability and Efficiency Metrics
Foseco India has demonstrated impressive profitability metrics, with a reported net profit of ₹79 Cr and an operating profit margin (OPM) of 17%. The company’s return on equity (ROE) stood at an impressive 23.3%, while the return on capital employed (ROCE) was recorded at 31.3%. These figures indicate a strong ability to generate returns for shareholders and effectively utilize capital. The operating profit for December 2023 was ₹70 Cr, further reflecting the company’s operational efficiency. The interest coverage ratio (ICR) is exceptionally high at 706.36x, showcasing the firm’s ability to meet its interest obligations comfortably. However, the net profit margin has shown some fluctuations, with a decrease to 13.91% in March 2025 from 15.28% in the previous year. Overall, Foseco’s profitability metrics are robust compared to typical industry standards, indicating strong financial health.
Balance Sheet Strength and Financial Ratios
Foseco’s balance sheet reflects significant strength, with total assets reported at ₹522 Cr and total liabilities at ₹420 Cr as of June 2025. The company maintains minimal borrowings, amounting to just ₹2 Cr, which positions it favorably regarding financial leverage. Reserves have increased to ₹363 Cr, indicating retained earnings that bolster the company’s equity. The price-to-book value (P/BV) ratio stood at 7.48x, which is relatively high, suggesting that the market values the company significantly compared to its book value. Financial ratios such as the current ratio of 3.12 and quick ratio of 2.85 indicate strong liquidity, providing assurance of the company’s ability to meet short-term obligations. The enterprise value (EV) stood at ₹2,311.90 Cr, and the EV to EBITDA ratio at 21.31x reflects a premium valuation, indicative of investor confidence in the company’s growth prospects.
Shareholding Pattern and Investor Confidence
Foseco’s shareholding pattern reveals a strong promoter backing, with promoters holding 74.98% of the equity. The public holds 24.22%, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold marginal stakes of 0.12% and 0.68%, respectively. This concentrated promoter ownership can be a double-edged sword; while it provides stability, it may also limit liquidity. The number of shareholders has grown from 11,157 in December 2022 to 13,602 in June 2025, indicating increasing interest from the investing community. However, the low institutional participation may raise concerns regarding broader market acceptance. The gradual increase in DII ownership, from negligible levels to 0.68% by June 2025, suggests a growing recognition of the company among institutional investors, enhancing overall investor confidence.
Outlook, Risks, and Final Insight
The outlook for Foseco India appears optimistic, driven by strong revenue growth, robust profitability metrics, and a solid balance sheet. However, the company faces several risks, including its reliance on a concentrated promoter holding and low institutional investor participation, which may affect stock liquidity and market perception. Additionally, fluctuations in net profit margins could signal potential operational challenges. The high P/BV ratio indicates that the stock is trading at a premium, which could lead to volatility if earnings do not meet market expectations. Nevertheless, Foseco’s operational efficiency, as evidenced by its high ROCE and ICR, suggests that the company is well-equipped to navigate challenges. Conditional scenarios include the potential for continued growth if the company expands its market presence and diversifies its investor base, or a decline in market sentiment if operational performance falters or if external economic conditions adversely impact demand for its products.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Foseco India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 104 Cr. | 293 | 456/255 | 243 | 392 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,391 Cr. | 9,323 | 14,250/8,150 | 53.5 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 36.9 Cr. | 123 | 329/109 | 18.3 | 26.9 | 0.81 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 332 Cr. | 416 | 435/163 | 18.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,602.15 Cr | 1,600.06 | 68.03 | 334.84 | 0.39% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 103 | 106 | 111 | 121 | 123 | 122 | 123 | 125 | 141 | 136 | 149 | 157 |
| Expenses | 85 | 88 | 88 | 95 | 103 | 107 | 103 | 103 | 101 | 117 | 114 | 121 | 130 |
| Operating Profit | 14 | 15 | 18 | 15 | 18 | 16 | 20 | 20 | 24 | 24 | 23 | 27 | 27 |
| OPM % | 14% | 15% | 17% | 14% | 15% | 13% | 16% | 16% | 19% | 17% | 17% | 18% | 17% |
| Other Income | 1 | 2 | 2 | 5 | 17 | 7 | 5 | 4 | 4 | 4 | 6 | 4 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 2 |
| Profit before tax | 14 | 15 | 16 | 19 | 33 | 21 | 22 | 21 | 25 | 26 | 26 | 29 | 29 |
| Tax % | 26% | 26% | 25% | 26% | 17% | 29% | 25% | 25% | 26% | 26% | 26% | 26% | 26% |
| Net Profit | 11 | 11 | 12 | 14 | 28 | 15 | 16 | 16 | 18 | 19 | 20 | 22 | 22 |
| EPS in Rs | 16.53 | 17.11 | 19.20 | 22.30 | 43.31 | 23.13 | 25.54 | 24.82 | 28.97 | 29.95 | 30.61 | 33.93 | 33.71 |
Last Updated: August 1, 2025, 9:20 pm
Below is a detailed analysis of the quarterly data for Foseco India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 149.00 Cr. (Mar 2025) to 157.00 Cr., marking an increase of 8.00 Cr..
- For Expenses, as of Jun 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 121.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 9.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For OPM %, as of Jun 2025, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Mar 2025) to 17.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
- For Net Profit, as of Jun 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 33.71. The value appears to be declining and may need further review. It has decreased from 33.93 (Mar 2025) to 33.71, marking a decrease of 0.22.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:23 am
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 227 | 263 | 292 | 340 | 358 | 362 | 323 | 251 | 338 | 407 | 477 | 525 | 593 |
| Expenses | 196 | 224 | 241 | 285 | 306 | 312 | 276 | 230 | 294 | 343 | 408 | 434 | 488 |
| Operating Profit | 31 | 39 | 51 | 55 | 51 | 51 | 46 | 21 | 44 | 63 | 70 | 91 | 105 |
| OPM % | 13% | 15% | 17% | 16% | 14% | 14% | 14% | 8% | 13% | 16% | 15% | 17% | 18% |
| Other Income | 2 | 3 | 2 | 2 | 3 | 4 | 8 | 6 | 6 | 7 | 33 | 18 | 14 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 6 | 6 | 9 | 8 | 10 | 10 |
| Profit before tax | 27 | 38 | 48 | 51 | 48 | 50 | 50 | 21 | 43 | 61 | 95 | 98 | 108 |
| Tax % | 34% | 35% | 34% | 36% | 34% | 36% | 30% | 27% | 25% | 25% | 23% | 26% | |
| Net Profit | 18 | 25 | 32 | 33 | 32 | 32 | 35 | 15 | 33 | 46 | 73 | 73 | 79 |
| EPS in Rs | 27.90 | 38.50 | 49.68 | 51.80 | 49.43 | 50.17 | 54.07 | 24.18 | 51.15 | 71.98 | 114.27 | 114.35 | 124.07 |
| Dividend Payout % | 88% | 55% | 53% | 44% | 51% | 50% | 46% | 62% | 49% | 56% | 22% | 22% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 16% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 16% |
| 3 Years: | 31% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 39% |
| 3 Years: | 52% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 20% |
| 3 Years: | 23% |
| Last Year: | 23% |
Last Updated: September 5, 2025, 4:15 am
Balance Sheet
Last Updated: November 9, 2025, 2:01 pm
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 83 | 91 | 103 | 118 | 139 | 150 | 165 | 176 | 202 | 233 | 280 | 337 | 363 |
| Borrowings | 8 | 6 | 4 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Other Liabilities | 50 | 48 | 50 | 57 | 75 | 82 | 77 | 80 | 86 | 106 | 132 | 138 | 150 |
| Total Liabilities | 147 | 152 | 163 | 183 | 221 | 238 | 249 | 263 | 294 | 345 | 420 | 483 | 522 |
| Fixed Assets | 28 | 26 | 26 | 26 | 23 | 20 | 34 | 31 | 35 | 31 | 39 | 45 | 44 |
| CWIP | 0 | 1 | 1 | 0 | 1 | 6 | 2 | 5 | 0 | 1 | 1 | 2 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 119 | 125 | 136 | 157 | 197 | 213 | 213 | 227 | 259 | 313 | 379 | 436 | 476 |
| Total Assets | 147 | 152 | 163 | 183 | 221 | 238 | 249 | 263 | 294 | 345 | 420 | 483 | 522 |
Below is a detailed analysis of the balance sheet data for Foseco India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Equity Capital, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 6.00 Cr..
- For Reserves, as of Jun 2025, the value is 363.00 Cr.. The value appears strong and on an upward trend. It has increased from 337.00 Cr. (Dec 2024) to 363.00 Cr., marking an increase of 26.00 Cr..
- For Borrowings, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
- For Other Liabilities, as of Jun 2025, the value is 150.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 138.00 Cr. (Dec 2024) to 150.00 Cr., marking an increase of 12.00 Cr..
- For Total Liabilities, as of Jun 2025, the value is 522.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 483.00 Cr. (Dec 2024) to 522.00 Cr., marking an increase of 39.00 Cr..
- For Fixed Assets, as of Jun 2025, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Dec 2024) to 44.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Dec 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Other Assets, as of Jun 2025, the value is 476.00 Cr.. The value appears strong and on an upward trend. It has increased from 436.00 Cr. (Dec 2024) to 476.00 Cr., marking an increase of 40.00 Cr..
- For Total Assets, as of Jun 2025, the value is 522.00 Cr.. The value appears strong and on an upward trend. It has increased from 483.00 Cr. (Dec 2024) to 522.00 Cr., marking an increase of 39.00 Cr..
Notably, the Reserves (363.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 23.00 | 33.00 | 47.00 | 53.00 | 50.00 | 51.00 | 46.00 | 21.00 | 44.00 | 63.00 | 69.00 | 89.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 101 | 113 | 107 | 103 | 88 | 82 | 94 | 80 | 76 | 78 | 84 |
| Inventory Days | 32 | 32 | 35 | 35 | 29 | 36 | 39 | 32 | 43 | 32 | 46 | 47 |
| Days Payable | 86 | 73 | 80 | 81 | 109 | 111 | 130 | 173 | 136 | 146 | 160 | 155 |
| Cash Conversion Cycle | 49 | 60 | 68 | 61 | 23 | 12 | -8 | -46 | -13 | -37 | -36 | -23 |
| Working Capital Days | 49 | 56 | 72 | 70 | 45 | 31 | 20 | 3 | 21 | 11 | 9 | 24 |
| ROCE % | 29% | 38% | 45% | 44% | 36% | 33% | 30% | 12% | 22% | 28% | 32% | 31% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 114.35 | 114.28 | 71.98 | 51.16 | 24.17 |
| Diluted EPS (Rs.) | 114.35 | 114.28 | 71.98 | 51.16 | 24.17 |
| Cash EPS (Rs.) | 130.02 | 126.48 | 85.92 | 60.36 | 33.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 537.69 | 448.78 | 374.25 | 326.73 | 285.99 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 537.69 | 448.78 | 374.25 | 326.73 | 285.99 |
| Dividend / Share (Rs.) | 25.00 | 25.00 | 40.00 | 25.00 | 15.00 |
| Revenue From Operations / Share (Rs.) | 821.71 | 747.53 | 636.87 | 529.26 | 393.25 |
| PBDIT / Share (Rs.) | 169.88 | 142.70 | 109.97 | 77.04 | 42.28 |
| PBIT / Share (Rs.) | 154.21 | 130.50 | 96.03 | 67.83 | 33.02 |
| PBT / Share (Rs.) | 153.97 | 148.99 | 96.03 | 67.83 | 33.02 |
| Net Profit / Share (Rs.) | 114.35 | 114.28 | 71.98 | 51.16 | 24.17 |
| PBDIT Margin (%) | 20.67 | 19.08 | 17.26 | 14.55 | 10.75 |
| PBIT Margin (%) | 18.76 | 17.45 | 15.07 | 12.81 | 8.39 |
| PBT Margin (%) | 18.73 | 19.93 | 15.07 | 12.81 | 8.39 |
| Net Profit Margin (%) | 13.91 | 15.28 | 11.30 | 9.66 | 6.14 |
| Return on Networth / Equity (%) | 21.26 | 25.46 | 19.23 | 15.65 | 8.45 |
| Return on Capital Employeed (%) | 28.55 | 28.89 | 25.55 | 20.70 | 11.50 |
| Return On Assets (%) | 15.12 | 17.39 | 13.31 | 11.09 | 5.86 |
| Asset Turnover Ratio (%) | 1.16 | 1.25 | 1.27 | 1.21 | 0.98 |
| Current Ratio (X) | 3.12 | 2.84 | 2.91 | 2.98 | 2.74 |
| Quick Ratio (X) | 2.85 | 2.59 | 2.72 | 2.72 | 2.58 |
| Inventory Turnover Ratio (X) | 7.69 | 9.37 | 10.15 | 10.47 | 8.17 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 35.00 | 34.73 | 19.54 | 20.68 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 31.62 | 29.09 | 16.56 | 14.95 |
| Earning Retention Ratio (%) | 0.00 | 65.00 | 65.27 | 80.46 | 79.32 |
| Cash Earning Retention Ratio (%) | 0.00 | 68.38 | 70.91 | 83.44 | 85.05 |
| Interest Coverage Ratio (X) | 706.36 | 1246.69 | 0.00 | 0.00 | 38571.14 |
| Interest Coverage Ratio (Post Tax) (X) | 476.44 | 836.82 | 0.00 | 0.00 | 22053.57 |
| Enterprise Value (Cr.) | 2311.90 | 2210.85 | 1039.64 | 758.83 | 700.49 |
| EV / Net Operating Revenue (X) | 4.41 | 4.63 | 2.56 | 2.24 | 2.79 |
| EV / EBITDA (X) | 21.31 | 24.26 | 14.80 | 15.42 | 25.94 |
| MarketCap / Net Operating Revenue (X) | 4.90 | 5.11 | 3.02 | 2.69 | 3.33 |
| Retention Ratios (%) | 0.00 | 64.99 | 65.26 | 80.45 | 79.31 |
| Price / BV (X) | 7.48 | 8.52 | 5.14 | 4.35 | 4.59 |
| Price / Net Operating Revenue (X) | 4.90 | 5.11 | 3.02 | 2.69 | 3.33 |
| EarningsYield | 0.02 | 0.02 | 0.03 | 0.03 | 0.01 |
After reviewing the key financial ratios for Foseco India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 114.35. This value is within the healthy range. It has increased from 114.28 (Mar 24) to 114.35, marking an increase of 0.07.
- For Diluted EPS (Rs.), as of Mar 25, the value is 114.35. This value is within the healthy range. It has increased from 114.28 (Mar 24) to 114.35, marking an increase of 0.07.
- For Cash EPS (Rs.), as of Mar 25, the value is 130.02. This value is within the healthy range. It has increased from 126.48 (Mar 24) to 130.02, marking an increase of 3.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 537.69. It has increased from 448.78 (Mar 24) to 537.69, marking an increase of 88.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 537.69. It has increased from 448.78 (Mar 24) to 537.69, marking an increase of 88.91.
- For Dividend / Share (Rs.), as of Mar 25, the value is 25.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 25.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 821.71. It has increased from 747.53 (Mar 24) to 821.71, marking an increase of 74.18.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 169.88. This value is within the healthy range. It has increased from 142.70 (Mar 24) to 169.88, marking an increase of 27.18.
- For PBIT / Share (Rs.), as of Mar 25, the value is 154.21. This value is within the healthy range. It has increased from 130.50 (Mar 24) to 154.21, marking an increase of 23.71.
- For PBT / Share (Rs.), as of Mar 25, the value is 153.97. This value is within the healthy range. It has increased from 148.99 (Mar 24) to 153.97, marking an increase of 4.98.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 114.35. This value is within the healthy range. It has increased from 114.28 (Mar 24) to 114.35, marking an increase of 0.07.
- For PBDIT Margin (%), as of Mar 25, the value is 20.67. This value is within the healthy range. It has increased from 19.08 (Mar 24) to 20.67, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 25, the value is 18.76. This value is within the healthy range. It has increased from 17.45 (Mar 24) to 18.76, marking an increase of 1.31.
- For PBT Margin (%), as of Mar 25, the value is 18.73. This value is within the healthy range. It has decreased from 19.93 (Mar 24) to 18.73, marking a decrease of 1.20.
- For Net Profit Margin (%), as of Mar 25, the value is 13.91. This value exceeds the healthy maximum of 10. It has decreased from 15.28 (Mar 24) to 13.91, marking a decrease of 1.37.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.26. This value is within the healthy range. It has decreased from 25.46 (Mar 24) to 21.26, marking a decrease of 4.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 28.55. This value is within the healthy range. It has decreased from 28.89 (Mar 24) to 28.55, marking a decrease of 0.34.
- For Return On Assets (%), as of Mar 25, the value is 15.12. This value is within the healthy range. It has decreased from 17.39 (Mar 24) to 15.12, marking a decrease of 2.27.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.16. It has decreased from 1.25 (Mar 24) to 1.16, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 3.12. This value exceeds the healthy maximum of 3. It has increased from 2.84 (Mar 24) to 3.12, marking an increase of 0.28.
- For Quick Ratio (X), as of Mar 25, the value is 2.85. This value exceeds the healthy maximum of 2. It has increased from 2.59 (Mar 24) to 2.85, marking an increase of 0.26.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.69. This value is within the healthy range. It has decreased from 9.37 (Mar 24) to 7.69, marking a decrease of 1.68.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 35.00 (Mar 24) to 0.00, marking a decrease of 35.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 31.62 (Mar 24) to 0.00, marking a decrease of 31.62.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 65.00 (Mar 24) to 0.00, marking a decrease of 65.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 68.38 (Mar 24) to 0.00, marking a decrease of 68.38.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 706.36. This value is within the healthy range. It has decreased from 1,246.69 (Mar 24) to 706.36, marking a decrease of 540.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 476.44. This value is within the healthy range. It has decreased from 836.82 (Mar 24) to 476.44, marking a decrease of 360.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,311.90. It has increased from 2,210.85 (Mar 24) to 2,311.90, marking an increase of 101.05.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.41. This value exceeds the healthy maximum of 3. It has decreased from 4.63 (Mar 24) to 4.41, marking a decrease of 0.22.
- For EV / EBITDA (X), as of Mar 25, the value is 21.31. This value exceeds the healthy maximum of 15. It has decreased from 24.26 (Mar 24) to 21.31, marking a decrease of 2.95.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.90. This value exceeds the healthy maximum of 3. It has decreased from 5.11 (Mar 24) to 4.90, marking a decrease of 0.21.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 64.99 (Mar 24) to 0.00, marking a decrease of 64.99.
- For Price / BV (X), as of Mar 25, the value is 7.48. This value exceeds the healthy maximum of 3. It has decreased from 8.52 (Mar 24) to 7.48, marking a decrease of 1.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.90. This value exceeds the healthy maximum of 3. It has decreased from 5.11 (Mar 24) to 4.90, marking a decrease of 0.21.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Foseco India Ltd:
- Net Profit Margin: 13.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 28.55% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.26% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 476.44
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.85
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 40.4 (Industry average Stock P/E: 68.03)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Gat Nos. 922 & 923, Pune District Maharashtra 412208 | investor.grievance@vesuvius.com http://www.fosecoindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Moti Kirpalani | Chairperson & Director |
| Mr. Prasad Chavare | Managing Director & CEO |
| Mr. Mark Russel Collis | Director |
| Ms. Anita Belani | Director |
| Ms. Karena Cancilleri | Director |
| Mr. Amitabha Mukhopadhyay | Director |
FAQ
What is the intrinsic value of Foseco India Ltd?
Foseco India Ltd's intrinsic value (as of 24 November 2025) is 4381.12 which is 16.01% lower the current market price of 5,216.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,334 Cr. market cap, FY2025-2026 high/low of 6,846/3,205, reserves of ₹363 Cr, and liabilities of 522 Cr.
What is the Market Cap of Foseco India Ltd?
The Market Cap of Foseco India Ltd is 3,334 Cr..
What is the current Stock Price of Foseco India Ltd as on 24 November 2025?
The current stock price of Foseco India Ltd as on 24 November 2025 is 5,216.
What is the High / Low of Foseco India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Foseco India Ltd stocks is 6,846/3,205.
What is the Stock P/E of Foseco India Ltd?
The Stock P/E of Foseco India Ltd is 40.4.
What is the Book Value of Foseco India Ltd?
The Book Value of Foseco India Ltd is 579.
What is the Dividend Yield of Foseco India Ltd?
The Dividend Yield of Foseco India Ltd is 0.48 %.
What is the ROCE of Foseco India Ltd?
The ROCE of Foseco India Ltd is 31.3 %.
What is the ROE of Foseco India Ltd?
The ROE of Foseco India Ltd is 23.3 %.
What is the Face Value of Foseco India Ltd?
The Face Value of Foseco India Ltd is 10.0.